These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 30541395)

  • 1. Economic costs and health-related quality of life associated with individual specific reminiscence: Results from the InspireD Feasibility Study.
    Ferry F; Ryan A; McCauley CO; Laird EA; Gibson A; Mulvenna MD; Bond R; Bunting B; Curran K
    Dementia (London); 2020 Oct; 19(7):2166-2183. PubMed ID: 30541395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial.
    Orgeta V; Leung P; Yates L; Kang S; Hoare Z; Henderson C; Whitaker C; Burns A; Knapp M; Leroi I; Moniz-Cook ED; Pearson S; Simpson S; Spector A; Roberts S; Russell IT; de Waal H; Woods RT; Orrell M
    Health Technol Assess; 2015 Aug; 19(64):1-108. PubMed ID: 26292178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.
    Mulhern B; Rowen D; Brazier J; Smith S; Romeo R; Tait R; Watchurst C; Chua KC; Loftus V; Young T; Lamping D; Knapp M; Howard R; Banerjee S
    Health Technol Assess; 2013 Feb; 17(5):v-xv, 1-140. PubMed ID: 23402232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Mobile Technology to Provide Personalized Reminiscence for People Living With Dementia and Their Carers: Appraisal of Outcomes From a Quasi-Experimental Study.
    Laird EA; Ryan A; McCauley C; Bond RB; Mulvenna MD; Curran KJ; Bunting B; Ferry F; Gibson A
    JMIR Ment Health; 2018 Sep; 5(3):e57. PubMed ID: 30206053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEDREV (pharmacy-health psychology intervention in people living with dementia with behaviour that challenges): the feasibility of measuring clinical outcomes and costs of the intervention.
    Maidment ID; Barton G; Campbell N; Shaw R; Seare N; Fox C; Iliffe S; Randle E; Hilton A; Brown G; Barnes N; Wilcock J; Gillespie S; Damery S
    BMC Health Serv Res; 2020 Mar; 20(1):157. PubMed ID: 32122341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and effectiveness of a telephone-based social support intervention for informal caregivers of people with dementia: Study protocol of the TALKING TIME project.
    Berwig M; Dichter MN; Albers B; Wermke K; Trutschel D; Seismann-Petersen S; Halek M
    BMC Health Serv Res; 2017 Apr; 17(1):280. PubMed ID: 28415999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community Occupational Therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID]) study: A single-blind, randomised controlled trial.
    Wenborn J; O'Keeffe AG; Mountain G; Moniz-Cook E; King M; Omar RZ; Mundy J; Burgess J; Poland F; Morris S; Pizzo E; Vernooij-Dassen M; Challis D; Michie S; Russell I; Sackley C; Graff M; Swinson T; Crellin N; Hynes S; Stansfeld J; Orrell M
    PLoS Med; 2021 Jan; 18(1):e1003433. PubMed ID: 33395437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
    Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
    Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology.
    Smith SC; Lamping DL; Banerjee S; Harwood R; Foley B; Smith P; Cook JC; Murray J; Prince M; Levin E; Mann A; Knapp M
    Health Technol Assess; 2005 Mar; 9(10):1-93, iii-iv. PubMed ID: 15774233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial.
    Henderson C; Knapp M; Stirling S; Shepstone L; High J; Ballard C; Bentham P; Burns A; Farina N; Fox C; Fountain J; Francis P; Howard R; Leroi I; Livingston G; Nilforooshan R; Nurock S; O'Brien JT; Price A; Swart AM; Tabet N; Telling T; Thomas AJ; Banerjee S
    Int Psychogeriatr; 2022 Oct; 34(10):905-917. PubMed ID: 35852256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proxy reporting of health-related quality of life for people with dementia: a psychometric solution.
    Smith SC; Hendriks AAJ; Cano SJ; Black N
    Health Qual Life Outcomes; 2020 May; 18(1):148. PubMed ID: 32448322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of Memory Assessment Services for the diagnosis and early support of patients with dementia in England.
    Gomes M; Pennington M; Wittenberg R; Knapp M; Black N; Smith S
    J Health Serv Res Policy; 2017 Oct; 22(4):226-235. PubMed ID: 28622732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial.
    Livingston G; Barber J; Marston L; Stringer A; Panca M; Hunter R; Cooper C; Laybourne A; La Frenais F; Reeves S; Manela M; Lambe K; Banerjee S; Rapaport P
    Lancet Psychiatry; 2019 Apr; 6(4):293-304. PubMed ID: 30872010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.
    Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R
    Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.